Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

38.19
+1.183.19%
Volume:1.24M
Turnover:47.36M
Market Cap:4.57B
PE:-7.46
High:38.74
Open:37.23
Low:36.89
Close:37.01
52wk High:59.39
52wk Low:29.31
Shares:119.66M
Float Shares:119.09M
Volume Ratio:0.84
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1182
EPS(LYR):-5.2646
ROE:-572.15%
ROA:-24.87%
PB:-12.39
PE(LYR):-7.25

Loading ...

Cytokinetics Positioned for Success: Strong Financials and Strategic Advancements Drive Buy Rating

TIPRANKS
·
Aug 08

Cytokinetics (CYTK) Gets a Buy from Barclays

TIPRANKS
·
Aug 08

Cytokinetics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Cytokinetics Q2 EPS $(1.12) Beats $(1.37) Estimate, Sales $66.769M Beat $2.382M Estimate

Benzinga
·
Aug 08

BRIEF-Cytokinetics Q2 Basic EPS USD -1.12

Reuters
·
Aug 08

Fady Ibraham Malik, EVP Research & Development, Reports Disposal of Common Shares in Cytokinetics Inc

Reuters
·
Aug 06

Cytokinetics CEO Makes a Strategic Stock Sale

TIPRANKS
·
Aug 01

Cytokinetics CEO Robert I. Blum Reports Disposal of Common Shares

Reuters
·
Aug 01

BRIEF-Cytokinetics To Announce Second Quarter Results On August 7, 2025

Reuters
·
Jul 25

Cytokinetics to Announce Second Quarter Results on August 7, 2025

THOMSON REUTERS
·
Jul 25

Top Executive Sells Cytokinetics Stock in a Major Move

TIPRANKS
·
Jul 24

Cytokinetics EVP Fady Ibraham Malik Reports Disposal of Common Shares

Reuters
·
Jul 23

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
Jul 19

Cytokinetics CEO Makes a Significant Stock Move!

TIPRANKS
·
Jul 16

Robert I. Blum, President & CEO, Reports Disposal of Common Shares in Cytokinetics Inc

Reuters
·
Jul 16

Cytokinetics (CYTK) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jul 14

Cytokinetics Insiders Sold US$9.5m Of Shares Suggesting Hesitancy

Simply Wall St.
·
Jul 12

Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025

GlobeNewswire
·
Jul 10

Top Executive at Cytokinetics Makes Significant Stock Sale

TIPRANKS
·
Jul 09

Fady Ibraham Malik, EVP of Research & Development, Reports Disposal of Cytokinetics Common Shares

Reuters
·
Jul 09